Trevi Therapeutics
TRVI
TRVI
17 hedge funds and large institutions have $28.1M invested in Trevi Therapeutics in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$56K | |
| 2 | +$26.4K | |
| 3 | +$7.05K | |
| 4 |
First Manhattan
New York
|
+$3.2K |
| 5 |
WA
WealthTrust Axiom
Wayne,
Pennsylvania
|
+$2.23K |
Top Sellers
| 1 | -$1.57M | |
| 2 | -$169K | |
| 3 | -$65.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$29K |
| 5 |
Morgan Stanley
New York
|
-$3K |